We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Henry Schein (HSIC) Extends Partnership With Special Olympics
Read MoreHide Full Article
Henry Schein (HSIC - Free Report) recently extended its existing partnership with Special Olympics through 2025 to support health screening and education for its athletes at select events around the world. Through the collaboration, the company donates essential oral health and medical care products for the Special Olympics Healthy Athletes program in Australia, Canada, Germany, the United Kingdom and the United States.
The donations to Special Olympics Healthy Athletes are an initiative of Henry Schein Cares, HSIC’s global corporate social responsibility program.
Significance of the Partnership
The goal of the Healthy Athletes program is to support the physical and social-emotional well-being of people with intellectual disabilities (ID), reduce health disparities and increase life expectancy. Henry Schein’s donations are used during screenings in seven Healthy Athletes disciplines — Fit Feet (podiatry), FUNfitness (physical therapy), Health Promotion (better health and well-being), MedFest (sports physical exam), Strong Minds (emotional well-being), Healthy Young Athletes (pediatric screening) and Special Smiles (oral health).
Image Source: Zacks Investment Research
As a Spirit Partner of Special Olympics, the company actively serves an important role in Special Olympics’ health programming. Additionally, the partnership empowers and encourages healthcare providers to volunteer their time and services to increase the knowledge of best practices in caring for and communicating with people with ID. More recently, Henry Schein has donated a range of essential healthcare products for the June 2023 Special Olympics World Games held in Berlin, Germany.
More on the News
Individuals with ID are often denied health services despite severe need and higher health risks and die, on average, 16 years sooner than the general population. Henry Schein’s strengthened partnership with Special Olympics helps expand access to care for an often-overlooked community, which is a core tenet of its corporate citizenship commitment. This also furthers their commitment to the Healthy Athletes program and health equity as a whole.
Since its inception in 1997, the Healthy Athletes program has delivered more than two million free health screenings and trained more than 300,000 healthcare professionals, clinical volunteers and students in using adapted screening protocols and communicating effectively with people with ID. These trainings also expand the healthcare provider’s capacity to serve people with ID beyond Special Olympics events.
Notable Developments
Earlier in April 2024, Henry Schein expanded into the high-growth extremities market with the strategic acquisition of TriMed Inc. Together with the established presence and reputation of the orthopedic solutions provider, the company aims to expand its product offering and offer comprehensive orthopedic solutions to its customers. The transaction is expected to be neutral to Henry Schein’s 2024 non-GAAP earnings per share and accretive thereafter.
Price Performance
In the past six months, shares of the company have advanced 5.8% compared with the industry’s rise of 7.8%.
Zacks Rank and Key Picks
Henry Schein currently carries a Zacks Rank #3 (Hold).
Hims & Hers Heath stock has rallied 19.7% in the past year. Earnings estimates for the company have risen from 10 cents to 18 cents in 2024 and from 23 cents to 32 cents in 2025 in the past 30 days.
HIMS’ earnings beat estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 79.2%. In the last reported quarter, it posted an earnings surprise of a staggering 150%.
Estimates for High Tide’s 2024 earnings per share have remained breakeven in the past 30 days. Shares of the company have surged 69.7% upward in the past year against the industry’s fall of 3.2%.
HITI’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 91.7%. In the last reported quarter, it delivered an earnings surprise of 100%.
Estimates for ResMed’s fiscal 2024 earnings per share have moved up 2% to $7.59 in the past seven days. Shares of the company have fallen 6.3% in the past year compared with the industry’s 3.2% decrease.
RMD’s earnings surpassed estimates in three of the trailing four quarters and missed on one occasion, the average surprise being 2.8%. In the last reported quarter, it delivered an average earnings surprise of 10.9%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Henry Schein (HSIC) Extends Partnership With Special Olympics
Henry Schein (HSIC - Free Report) recently extended its existing partnership with Special Olympics through 2025 to support health screening and education for its athletes at select events around the world. Through the collaboration, the company donates essential oral health and medical care products for the Special Olympics Healthy Athletes program in Australia, Canada, Germany, the United Kingdom and the United States.
The donations to Special Olympics Healthy Athletes are an initiative of Henry Schein Cares, HSIC’s global corporate social responsibility program.
Significance of the Partnership
The goal of the Healthy Athletes program is to support the physical and social-emotional well-being of people with intellectual disabilities (ID), reduce health disparities and increase life expectancy. Henry Schein’s donations are used during screenings in seven Healthy Athletes disciplines — Fit Feet (podiatry), FUNfitness (physical therapy), Health Promotion (better health and well-being), MedFest (sports physical exam), Strong Minds (emotional well-being), Healthy Young Athletes (pediatric screening) and Special Smiles (oral health).
Image Source: Zacks Investment Research
As a Spirit Partner of Special Olympics, the company actively serves an important role in Special Olympics’ health programming. Additionally, the partnership empowers and encourages healthcare providers to volunteer their time and services to increase the knowledge of best practices in caring for and communicating with people with ID. More recently, Henry Schein has donated a range of essential healthcare products for the June 2023 Special Olympics World Games held in Berlin, Germany.
More on the News
Individuals with ID are often denied health services despite severe need and higher health risks and die, on average, 16 years sooner than the general population. Henry Schein’s strengthened partnership with Special Olympics helps expand access to care for an often-overlooked community, which is a core tenet of its corporate citizenship commitment. This also furthers their commitment to the Healthy Athletes program and health equity as a whole.
Since its inception in 1997, the Healthy Athletes program has delivered more than two million free health screenings and trained more than 300,000 healthcare professionals, clinical volunteers and students in using adapted screening protocols and communicating effectively with people with ID. These trainings also expand the healthcare provider’s capacity to serve people with ID beyond Special Olympics events.
Notable Developments
Earlier in April 2024, Henry Schein expanded into the high-growth extremities market with the strategic acquisition of TriMed Inc. Together with the established presence and reputation of the orthopedic solutions provider, the company aims to expand its product offering and offer comprehensive orthopedic solutions to its customers. The transaction is expected to be neutral to Henry Schein’s 2024 non-GAAP earnings per share and accretive thereafter.
Price Performance
In the past six months, shares of the company have advanced 5.8% compared with the industry’s rise of 7.8%.
Zacks Rank and Key Picks
Henry Schein currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader medical space are Hims & Hers Health (HIMS - Free Report) , High Tide (HITI - Free Report) and ResMed (RMD - Free Report) . While Hims & Hers Health and High Tide each sport a Zacks Rank #1 (Strong Buy), ResMed presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Hims & Hers Heath stock has rallied 19.7% in the past year. Earnings estimates for the company have risen from 10 cents to 18 cents in 2024 and from 23 cents to 32 cents in 2025 in the past 30 days.
HIMS’ earnings beat estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 79.2%. In the last reported quarter, it posted an earnings surprise of a staggering 150%.
Estimates for High Tide’s 2024 earnings per share have remained breakeven in the past 30 days. Shares of the company have surged 69.7% upward in the past year against the industry’s fall of 3.2%.
HITI’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 91.7%. In the last reported quarter, it delivered an earnings surprise of 100%.
Estimates for ResMed’s fiscal 2024 earnings per share have moved up 2% to $7.59 in the past seven days. Shares of the company have fallen 6.3% in the past year compared with the industry’s 3.2% decrease.
RMD’s earnings surpassed estimates in three of the trailing four quarters and missed on one occasion, the average surprise being 2.8%. In the last reported quarter, it delivered an average earnings surprise of 10.9%.